BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

N/A
indicator

Nifty Healthcare Index

1D
1M
3M
6M
1Y
5Y
empty graph

Nifty Healthcare Index Performance

Day's Range

Low

₹16,467.35

High

₹16,588.20

52 Week Range

Low

₹13,536.50

High

₹16,921.05

Previous Close ₹16,581.85
Day's Range ₹16,467.35 - ₹16,588.20
Open ₹16,569.45
52 Week Range ₹13,536.50 - ₹16,921.05
Volume 4,40,77,223

Nifty Healthcare Index Companies

Company Name LTP (₹) Change (₹) Sector
Cipla Ltd. 1450.00 Arrow -8.80 (-0.60%) Healthcare
Dr. Reddy's Laboratories Ltd. 1200.00 Arrow -6.00 (-0.50%) Healthcare
Lupin Ltd. 2235.00 Arrow -15.30 (-0.68%) Healthcare
Torrent Pharmaceuticals Ltd. 4833.00 Arrow -81.50 (-1.66%) Healthcare
Abbott India Ltd. 27060.00 Arrow -560.00 (-2.03%) Healthcare
Apollo Hospitals Enterprise Ltd. 8920.50 Arrow 320.50 (3.73%) Healthcare
Ipca Laboratories Ltd. 1734.20 Arrow -62.10 (-3.46%) Healthcare
Sun Pharmaceutical Industries Ltd. 1930.00 Arrow -2.00 (-0.10%) Healthcare
Aurobindo Pharma Ltd. 1622.10 Arrow -41.30 (-2.48%) Healthcare
Glenmark Pharmaceuticals Ltd. 2318.40 Arrow -1.60 (-0.07%) Healthcare

All Indices

Index Name Market Value 52W High 52W Low
Nifty 50 24366.0 26373.20 22182.55
Nifty IT 31357.75 40301.40 25699.10
Nifty Next 50 74486.55 74878.45 59896.10
NIFTY50 USD Index 8846.65 10443.40 8132.40
Nifty Bank 57491.1 61764.85 49954.85
NIFTY Midcap 100 63782.15 64139.05 52032.85
Nifty 500 23594.9 24144.20 20385.65
Nifty Midcap 50 18260.65 18403.50 14804.55
Nifty 100 25524.85 26975.15 22720.45
Nifty FMCG 48615.05 58485.05 45334.15

Latest News

Aug
13
2026
EQUITY Posted on Aug 13th 2026

Max Healthcare Institute informs about grant of options under ESOS

Max Healthcare Institute has informed that Nomination and Remuneration Committee (‘NRC’) of the Company in its meeting held today, August 13, 2026, has approved the grant of 3,61,827 stock options to eligible employees under Max Healthcare Institute - Employee Stock Option Scheme 2022. Details pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure. The NRC meeting commenced at 7.50 am (IST) and concluded at 8.20 am (IST). This disclosure will also be hosted on Company's website: ww.maxhealthcare.in.

The above information is a part of company’s filings submitted to BSE. 

Read More
Aug
10
2026
EQUITY Posted on Aug 10th 2026

Glenmark Pharmaceuticals informs about allotment of shares under ESOP

Glenmark Pharmaceuticals has informed that the Company has allotted 23,863 Equity Shares of Re 1 each on August 10, 2026, to the grantee who had exercised the options under the Company's Employee Stock Option Plan 2016 (ESOP 2016). With this allotment, the paid-up capital of the Company has increased from Rs 28,22,00,809 divided into 28,22,00,809 number of equity shares of face value Re 1 each to Rs. 28,22,24,672 divided into 28,22,24,672 number of equity shares of face value Re 1 each. The details as required under the SEBI (Share Based Employee Benefits and Sweat equity) Regulations, 2021 are enclosed as Annexure - I.

The above information is a part of company’s filings submitted to BSE.  

Read More
Aug
7
2026
EQUITY Posted on Aug 7th 2026

Lupin informs about revised investor presentation

Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that it enclosed a copy of the Investor Presentation (Revised) on the Unaudited Financial Results of the Company for the quarter ended on June 30, 2026
The above information is a part of company’s filings submitted to BSE.  
Read More
Aug
6
2026
EQUITY Posted on Aug 6th 2026

Biocon informs about earnings call

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Biocon has informed that it enclosed the presentation with respect to Q1 FY27 Earnings Call to be conducted on August 06, 2026. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Read More
Aug
4
2026
EQUITY Posted on Aug 4th 2026

Aurobindo Pharma informs about press release

Aurobindo Pharma has informed that it enclosed copies of the Notice published in the newspapers, Business Standard and Nava Telangana on August 4, 2026, intimating the shareholders about dispatch (through e-mail only) of the Notice of 39th Annual General Meeting of the Company to be held on Thursday, August 27, 2026, at 3:30 pm IST through Video Conferencing (VC) / Other Audio Visual Means(OAVM) and Annual Report for the financial year 2025-26, e-voting information and Book Closure dates.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Frequently Asked Questions

What is the Previous Close of NIFTYHEALTH index?

The previous close of NIFTYHEALTH index is ₹16505.3 as of 2026-08-14.

The total volume of NIFTYHEALTH index is 44077223.00 as of 2026-08-14.

The percentage change in value of NIFTYHEALTH index is -0.46% as of 2026-08-14.

The absolute increase in NIFTYHEALTH index value since the previous trading day is ₹-76.55 as of 2026-08-14.

A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.

View More
Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore